MedTrace Logo

Platelet Activation Affecting the Rate of Vascular Access Patency

NCT05165797 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-12-21

No results posted yet for this study

Summary

In the case of cardiovascular diseases such as coronary artery disease, cerebrovascular disease, and peripheral arterial disease, there are many studies that the use of antiplatelet agents is very helpful in improving the vascular patency rate, but there are not many studies on the use of antiplatelet agents in the dialysis approach. The basis for use is insufficient. There is a lack of research on whether maintaining a state in which platelet activation is suppressed is helpful in improving dialysis access patency. Therefore, we conducted this study to determine whether the degree of platelet activation affects the patency of vascular access.

Conditions

  • Platelet Activation
  • Hemodialysis Fistula Thrombosis

Interventions

BIOLOGICAL

platelet activation factors

platelet activation factors of subject blood

Sponsors & Collaborators

  • Korea University Anam Hospital

    lead OTHER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2021-12-31
Completion
2022-07-01

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05165797 on ClinicalTrials.gov